2013-12-11 21:23:01 -
DUBLIN, Ireland (Research and Markets) Research and Markets
( www.researchandmarkets.com/research/4caf77/ariaariad_pharma) has announced the addition of the "(ARIA)ARIAD PHARMACEUTICALS INC - Quantitative Valuation Report" company profile to their offering.
Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast Model and Ratings Model are incorporated to give you a well-rounded analysis from three different perspectives. Consensus EPS trend and Earnings Surprise statistics provide additional insights. Also, detailed Company Profile, Fair Valuation; 1-3-6 month and 1-2-3 yr forecasts, 1-5 Engine Rating, Multi-stock comparison, Financials, Earnings Estimates, Risk Assessment, Data Summary and much more.
Each of our Quantitative Valuation reports Provides:
- Our Rating
- Investment-Style Rating
- Return Forecasts
- Market Ratio-Based Valuation
- Quantitative Summary
- Earnings Report
- Analyst Expectations
- Annual Financials
- Quarterly Financial
Independent, numbers-based, objective Equity Research
Use this report to help to:
- Optimize your equity portfolio for the best risk/return ratio.
- Forecast equity portfolios value next year.
- Find a fair value for stocks and forecast their future prospects.
- Determine the chances of gain or loss on current holdings.
- Find momentum